Skip to main content

ORIGINAL RESEARCH article

Front. Immunol.
Sec. Inflammation
Volume 15 - 2024 | doi: 10.3389/fimmu.2024.1425885
This article is part of the Research Topic Community Series in Pathogenetic mechanism and therapeutic target for inflammation in autoimmune disease: Volume II View all articles

Accelerated calciprotein crystallization time (T50) is correlated with impaired lung diffusion capacity in systemic sclerosis

Provisionally accepted
Marija Geroldinger-Simic Marija Geroldinger-Simic 1,2Azmat Sohail Azmat Sohail 2Mehdi Razazian Mehdi Razazian 2Beatrice Krennmayr Beatrice Krennmayr 2Victoria Pernsteiner Victoria Pernsteiner 1Thomas Putz Thomas Putz 1Helmut K. Lackner Helmut K. Lackner 3Andreas Pasch Andreas Pasch 2,4Norbert Sepp Norbert Sepp 1Ioana Alesutan Ioana Alesutan 2Jakob Voelkl Jakob Voelkl 2,5,6*
  • 1 Ordensklinikum Linz, Linz, Upper Austria, Austria
  • 2 Johannes Kepler University of Linz, Linz, Austria
  • 3 Medical University of Graz, Graz, Styria, Austria
  • 4 Calciscon AG, Nidau, Switzerland
  • 5 CharitĂ© University Medicine Berlin, Berlin, Baden-Wurttemberg, Germany
  • 6 Partner site Berlin, German Center for Cardiovascular Research (DZHK), Berlin, Berlin, Germany

The final, formatted version of the article will be published soon.

    Systemic sclerosis (SSc) is a complex auto-immune disease characterized by vascular damage, inflammation, fibrosis and calcinosis, where pulmonary involvement is the leading cause of mortality. Calciprotein particles (CPPs) are increasingly formed upon disbalance of the physiological mineral buffering system and induce pro-inflammatory effects. This exploratory study investigated whether functional indicators of the endogenous mineral buffering system are dysregulated in SSc and linked to disease activity. Methods T50 (calciprotein crystallization test or serum calcification propensity) and hydrodynamic radius of secondary CPPs (CPP2) were determined in serum samples from 78 SSc patients and 44 controls without SSc, and were associated with disease activity markers of SSc.T50 was reduced and CPP2 radius was increased in SSc patients as compared to controls, indicating a deranged mineral buffering system. This was accompanied by slightly higher serum phosphate and PTH levels in SSc patients, while iFGF23 was not significantly modified. Longitudinally, all parameters remained unchanged over time in SSc patients, only iFGF23 increased. While the modified Rodnan skin score showed some inconsistent correlations with mineral buffering indicators, their association was not independent of other factors. However, lower T50 was significantly correlated to reduced lung diffusion capacity and this association remained significant in a multivariate linear regression model.This study provides indications for a disturbed mineral buffering system in SSc. Increased serum calcification propensity (lower T50) is correlated with impaired lung diffusion capacity, suggesting a possible role of deranged mineral buffering in disease progression. Further studies are required to confirm these observations in larger cohorts and to investigate a putative functional relevance.

    Keywords: Mineral buffering, Serum calcification propensity, Calciprotein particles, systemic sclerosis, Phosphate

    Received: 30 Apr 2024; Accepted: 29 Aug 2024.

    Copyright: © 2024 Geroldinger-Simic, Sohail, Razazian, Krennmayr, Pernsteiner, Putz, Lackner, Pasch, Sepp, Alesutan and Voelkl. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

    * Correspondence: Jakob Voelkl, Johannes Kepler University of Linz, Linz, Austria

    Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.